BioMarin Pharmaceutical Inc. buy klostergang
Start price
18.06.15
/
50%
€114.81
Target price
13.07.15
€130.00
Performance (%)
13.38%
End price
13.07.15
€130.17
Summary
This prediction ended on 13.07.15 with a price of €130.17. The prediction had a final performance of 13.38%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| BioMarin Pharmaceutical Inc. | 5.440% | 5.440% | -16.006% | 14.469% |
| iShares Core DAX® | 0.597% | 3.083% | 16.090% | 16.439% |
| iShares Nasdaq 100 | 0.899% | 5.338% | 29.239% | 56.431% |
| iShares Nikkei 225® | 1.775% | -1.206% | 6.823% | 4.774% |
| iShares S&P 500 | 0.990% | 3.500% | 24.956% | 47.182% |
Comments by klostergang for this prediction
In the thread BioMarin Pharmaceutical Inc. diskutieren
gut am Markt :
Biomarin Pharmaceutical Inc develops and commercializes pharmaceuticals for serious diseases and medical conditions. Its product portfolio is comprised of five product candidates Naglazyme, Kuvan, Aldurazyme, VIMIZIM and Firdapse.
Stopped prediction by klostergang for BioMarin Pharmaceutical Inc.
BioMarin Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€77.94
22.05.19
22.05.19
€117.79
04.11.21
04.11.21
-11.88%
17.06.21
17.06.21
